Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion type Assertion NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_head.
- NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion description "[ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_provenance.
- NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion evidence source_evidence_literature NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_provenance.
- NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion SIO_000772 16114055 NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_provenance.
- NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion wasDerivedFrom befree-2016 NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_provenance.
- NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion wasGeneratedBy ECO_0000203 NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_provenance.